What's new

Human medicines European public assessment report (EPAR): Elocta, efmoroctocog alfa, Date of authorisation: 18/11/2015, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Elocta, efmoroctocog alfa, Date of authorisation: 18/11/2015, Revision: 15, Status: Authorised

Apr 25, 2025 - 15:43
 0
Human medicines European public assessment report (EPAR): Elocta, efmoroctocog alfa, Date of authorisation: 18/11/2015, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Elocta, efmoroctocog alfa, Date of authorisation: 18/11/2015, Revision: 15, Status: Authorised
Read More

Tags:

Previous Article

Trump Administration Loosening Safety Requirements For Self-Driving Vehicles

Next Article

PG&E foresees ‘bright future’ with lower prices, higher demand

Related Posts

Orphan designation: Lomitapide Treatment of familial chylomicronaemia, 17/12/2010 Positive

Orphan designation: Lomitapide Treatment of familial ch...

Feb 24, 2025  0

Human medicines European public assessment report (EPAR): Ibandronic acid Accord, ibandronic acid, Date of authorisation: 18/11/2012, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025  0

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 11, 2025  0